The Center for Health Research (CHR) is a full-service research
facility available to all SPHHP faculty conducting externally
funded studies.
A core group of employees (including nurses) are available to coordinate studies; screen and/or interview study participants; obtain physical measurements such as weight, height and blood pressure; draw blood and other lab work; and code and enter data. Specialized equipment includes ultrasound equipment for testing carotid IMT and brachial reactivity.
For more information, contact Debbie Saltino, CHR coordinator, at saltino@buffalo.edu or 716-829-5604.
Principal Investigator: R. Lorraine Collins, PhD
Funding Agency: NIDA/NIH
Period: 9/209 – 8/2013
Abstract: Marijuana is the most popular illegal substance used by emerging and young adults (ages 18-25). The goal of this project is to evaluate whether physical activity/exercise serves as a positive alternative to marijuana use among regular marijuana users. Findings from this project will contribute to scientific knowledge about relationships between physical activity/exercise and marijuana use and contribute to the development of secondary prevention strategies to reduce substance-abuse risk among young adults who regularly use marijuana.
Principal Investigator: John Violanti, PhD
Funding
Agency: NIOSH
Period: 9/2010 -8/2015
Abstract: Police work is one of the most stressful jobs
in society, but little is known about the effects of this stress on
an officer’s long-term health. The research will study how
job stress affects officers over time and will provide information
on specific causes of stress on police. The findings will be used
to develop prevention programs for officers.
Principal Investigator: John Violanti, PhD
Funding Agency: CDC
Period: 8/2012 – 10/2015
Abstract: Research has been conducted on associations
between cardiovascular diseases and larger blood vessels, but
investigations of very small blood vessels have been far more
limited. Researchers will use retinal images from a high resolution
camera to examine small microvascular vessels, which may be
associated with CVD. Retinal microvascular changes have been shown
to be associated with chronic hypertension and clinical
cardiovascular disease outcomes. Retinal arteriolar narrowing also
is known to be associated with subclinical markers of
cardiovascular disease. The study will also assess three
cardiovascular biomarkers: Cystatin C, resistin and vitamin
D.